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ABSTRACT Membrane bound acyltransferase-3 (AT3) domain-containing proteins
are implicated in a wide range of carbohydrate O-acyl modifications, but their mech-
anism of action is largely unknown. O-antigen acetylation by AT3 domain-containing
acetyltransferases of Salmonella spp. can generate a specific immune response upon
infection and can influence bacteriophage interactions. This study integrates in situ
and in vitro functional analyses of two of these proteins, OafA and OafB (formerly
F2GtrC), which display an “AT3-SGNH fused” domain architecture, where an integral
membrane AT3 domain is fused to an extracytoplasmic SGNH domain. An in silico-
inspired mutagenesis approach of the AT3 domain identified seven residues which
are fundamental for the mechanism of action of OafA, with a particularly conserved
motif in TMH1 indicating a potential acyl donor interaction site. Genetic and in vitro
evidence demonstrate that the SGNH domain is both necessary and sufficient for li-
popolysaccharide acetylation. The structure of the periplasmic SGNH domain of OafB
identified features not previously reported for SGNH proteins. In particular, the
periplasmic portion of the interdomain linking region is structured. Significantly, this
region constrains acceptor substrate specificity, apparently by limiting access to the
active site. Coevolution analysis of the two domains suggests possible interdomain
interactions. Combining these data, we propose a refined model of the AT3-SGNH
proteins, with structurally constrained orientations of the two domains. These find-
ings enhance our understanding of how cells can transfer acyl groups from the cyto-
plasm to specific extracellular carbohydrates.
IMPORTANCE Acyltransferase-3 (AT3) domain-containing membrane proteins are in-
volved in O-acetylation of a diverse range of carbohydrates across all domains of
life. In bacteria they are essential in processes including symbiosis, resistance to anti-
microbials, and biosynthesis of antibiotics. Their mechanism of action, however, is
poorly characterized. We analyzed two acetyltransferases as models for this impor-
tant family of membrane proteins, which modify carbohydrates on the surface of the
pathogen Salmonella enterica, affecting immunogenicity, virulence, and bacterio-
phage resistance. We show that when these AT3 domains are fused to a periplasmic
partner domain, both domains are required for substrate acetylation. The data show
conserved elements in the AT3 domain and unique structural features of the
periplasmic domain. Our data provide a working model to probe the mechanism
and function of the diverse and important members of the widespread AT3 protein
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family, which are required for biologically significant modifications of cell-surface
carbohydrates.
KEYWORDS O-antigen, SGNH superfamily, Salmonella, acetylation, acyltransferase-3
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activity relationship, surface antigens
S
almonella infections are a considerable public health burden in both developing
and developed countries. Salmonella enterica subspecies enterica serovar Typhimu-
rium is estimated to cause more than 150,000 human deaths from gastroenteritis each
year (1, 2). A sublineage of this serovar is the dominant cause of invasive nontyphoidal
Salmonella (iNTS) bloodstream infections in Africa (3). The Typhi serovar of this sub-
species is the major cause of typhoid fever, resulting in over 200,000 deaths annually
(2, 4). In the United States, there are over 10,000 cases annually of these serovars
combined (5, 6).
Cell surface lipopolysaccharide (LPS) is an important virulence factor. The O-antigen,
the most distal and variable portion of LPS, is composed of repeating oligosaccharide
units whose composition and structure vary between species and, in the case of
Salmonella spp., between serovars. Modification of the O-antigen by alteration of sugar
linkages or addition of moieties such as glucose or acetate (7, 8) can influence
immunogenicity and virulence, and confer resistance to lytic phage infection (9–12).
Carbohydrates on the bacterial cell surface are frequently O-acetylated by acyltrans-
ferase proteins which contain a 10-transmembrane helix (TMH) acyltransferase-3 (AT3)
(InterPro IPR002656 and Pfam PF01757; also known as acyltransferase_3/putative
acetyl-CoA transporter, Transporter Classification Database number [TC] number
9.B.97). This family of proteins is widespread in eukaryotes and prokaryotes and is
involved in a range of acylation modifications. Examples of AT3-containing acetyltrans-
ferases from prokaryotes include those mediating peptidoglycan acetylation and con-
tributing to lysozyme resistance (13, 14), modification of root nodulation factors to
initiate symbioses (15), and O-antigen acetylation (9, 16, 17). Despite the involvement
of AT3-containing proteins in a wide range of reactions, their mechanism and structure
are poorly characterized.
Among bacterial AT3 carbohydrate acetyltransferases, there are two known domain
architectures, proteins consisting of an AT3 domain only (AT3-only) and an N-terminal
AT3 domain linked to an extracytoplasmic domain, commonly an SGNH domain
(AT3-SGNH fused). The SGNH domain is fused through addition of an 11th TMH and
linking region. Oac (in Shigella spp.) is an example of an AT3-only protein that is
essential for O-antigen acetylation (18), whereas OatA, the O-acetyltransferase of
peptidoglycan in Staphylococcus spp., is an example of an AT3-SGNH fused protein (14).
SGNH domains (InterPro number IPR036514) are a large and diverse family of small
catalytic domains of around 200 amino acids, originally characterized as a subgroup of
the GDSL hydrolase family based on their invariant residues, Ser, Gly, Asn, His—hence,
SGNH—which occur in four blocks of conserved sequence (19, 20). Members of this
family that are active against carbohydrates are also classified as CE3 family proteins in
the carbohydrate-active enzymes database (CAZy) (21). Subsequently, many more
proteins have been found to belong to this diverse family, and they no longer fully
adhere to the original paradigm of SGNH. However, most members typically contain a
catalytic triad of Ser, His, and Asp and oxyanion hole residues within the four blocks of
conserved sequence (22). It is not clear how the AT3 and SGNH domains function
together in AT3-SGNH fused carbohydrate acetyltransferases, nor how the AT3-only
proteins function independently of a linked periplasmic domain.
In Salmonella spp., there are two defined O-antigen acetyltransferases, OafA and
OafB (9, 10, 17, 23). Slauch et al. determined that the integral membrane protein OafA
from S. Typhimurium (17) acetylates the 2-hydroxyl group on the abequose moiety of
the O-antigen unique to this serovar (24). This results in acquisition of the O:5 serotype
(defined by the Kauffmann-White-Le Minor scheme) (25, 26), which is required for
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production of protective antibodies against S. Typhimurium infection (24, 27). Multiple
Salmonella serovars have a rhamnose moiety in the O-antigen that can be acetylated
at the 2- and 3-hydroxyl groups by F2GtrC proteins (9, 10, 23). As it is clear that F2GtrC
is an acetyltransferase with no functional relationship to the GtrABC glycosylating
proteins, we propose to rename this and orthologous rhamnose acetyltransferases
OafB. The name reflects the protein architecture (O-antigen acetyltransferase-fused B),
similar to what we suggest for OafA (O-antigen acetyltransferase-fused A).
In this work, using in situ and in vitro functional analysis of OafA and OafB O-antigen
acetyltransferases, we address the following key questions to further our understanding
of the mechanism of acetyl transport and transfer in AT3-SGNH fused acetyltrans-
ferases. (i) Are there essential residues in the membrane-bound AT3 domain that can
give clues to their role in acetyl transfer? (ii) Can we obtain insight into the architecture
of these proteins by elucidating the structure of the SGNH domain and its N-terminal
extension? (iii) What is the function of the SGNH domain, and can it function indepen-
dently of the AT3 domain?
RESULTS
In silico analysis identifies conserved features in the integral membrane do-
mains of bacterial AT3 acetyltransferases. The S. Typhimurium O-antigen acetyl-
FIG 1 OafA and OafB are membrane-bound O-acetyltransferases that acetylate the O-antigen of
Salmonella. (A) Schematic representation of OafA and OafB functional (colored) and transmembrane
(shaded) domains predicted by InterPro and TMHMM, respectively. C-term constructs used for in vitro
characterization are indicated below the protein. (B) Proposed mechanism of action of O-antigen
acetyltransferases during maturation of the LPS in the periplasm using OafA as an example. AT3, InterPro
IPR002656; SGNH, InterPro IPR013830.
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transferases OafA (17) and OafB (23) (formerly F2GtrC) are both predicted by InterPro
to contain an N-terminal AT3 domain (InterPro IPR002656, Pfam PF01757) fused to an
SGNH domain (InterPro IPR013830, Pfam PF14606, or Pfam PF13472) (28, 29) (Fig. 1A).
The AT3 domain has 10 TMH and an additional 11th helix that is presumably required to
localize the fused SGNH domain in the periplasm (Fig. 1A) (30); this prediction is supported
by experimental topology analysis of OafB (9) and consistent with topology analysis of Oac
(31), a comparison enabled by our detailed alignments (see below). Reinforcing the
widespread functions of these understudied proteins in bacteria, we identified in the
literature 30 bacterial AT3 domain-containing proteins with experimentally confirmed
carbohydrate acetyltransferase activity (9, 14–17, 32–55). Of these 30 proteins, 19 contain
just the AT3 domain, while 11, including OafA and OafB, have the fused AT3-SGNH
architecture (see Table S1 in the supplemental material). Previous work showed that in OafA
and OafB, the SGNH domain is essential for acetyltransferase activity (9, 56), and thus, we
propose the following working model for the mechanism of action (Fig. 1B). In AT3-SGNH
proteins, the AT3 domain passes an acetyl group from an unidentified donor in the
cytoplasm to the periplasmic face of the inner membrane. This acetyl group is then
transferred to the SGNH domain, which catalyzes specific carbohydrate O-acetylation
(Fig. 1B). To test this model, we first determined whether residues conserved between
AT3-only and AT3-SGNH acetyltransferases are important for acetyltransferase activity.
Alignments of the 30 characterized AT3 acetyltransferases along with an S. enterica
serovar Paratyphi A OafB homologue revealed that only 4 amino acids are invariant
across all 31 proteins, OafAH25, OafAF41, OafAG46, and OafAG202 (Fig. 2A, Fig. S1). OafAF41
FIG 2 Conservation in transmembrane domains of experimentally characterized bacterial AT3 carbohydrate acetyltransferases. The 100% identical residues are
colored orange, similar residues in 90% sequences are colored blue, and conserved small hydrophobic residues in transmembrane helices were not colored.
(A) Conserved residues across all 30 currently known experimentally characterized proteins and OafB-SPA. (B) Conservation in only AT3-SGNH fused proteins
in the alignment. See Table S1 for details of aligned sequences and Fig. S1 for full alignment.
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and OafAG46 belong to the FFXISG motif previously identified in unfused AT3 O-antigen
acetyltransferases (Fig. S1) (31). Two conserved residues are predicted in TMH1, sepa-
rated by 10 amino acids, in an R/K-X10-H motif (Fig. 2A, Fig. S1). A previously identified
RXXR motif (OafAR69,R72) in loop 2-3 is essential for activity in Shigella flexneri Oac
(OacR73,R75) (57) and OafB (OafBR71,R73) (9). This motif is highly (but not absolutely)
conserved across the 31 analyzed acetyltransferases.
We next examined features unique to the AT3 domains of AT3-SGNH fused acetyl-
transferases; these 11 sequences derive from diverse Gram-positive and Gram-negative
bacteria (Fig. 2B, Table S1). The most striking shared feature of AT3-SGNH fused
proteins is the highly conserved GG-F/Y-XGV-D/P/V motif located at the periplasmic
side of TMH2 (OafAG33-D39), which replaces a longer and more divergent loop region
between TMH1-2 in the nonfused AT3 proteins. Further conserved residues are seen in
the periplasmic loop between TMH3 and -4, including OafAS112, OafAN113, and
OafAY122. Together, these observations suggest shared key residues in both AT3-only
and AT3-SGNH fused proteins and possible adaption of AT3 domains in AT3-SGNH
fused acetyltransferases toward their function together with the fused SGNH domain.
Site-directed mutagenesis combined with in situ functional analysis of OafA
identifies functional residues within the AT3 domain. To determine the functional
importance of conserved residues in S. Typhimurium OafA (OafA-STM), we developed
an in situ functional assay using a double antibody LPS immunoblot. The assay
quantifies both the level of acetylated abequose (O:5) and the amount of LPS based on
the O-antigen core (Fig. 3). His-tagged OafA, or mutated versions thereof, were ex-
FIG 3 O-antigen acetylation and OafA expression from plasmid and chromosomally expressed protein.
(A) LPS immunoblot with crude LPS extracts from Salmonella enterica serovar Typhimurium; LT2 basal
O-antigen strain expressing OafA from pBADcLIC plasmid (pWT OafA-His), LT2 wild-type (WT) O-antigen
strain with a C-terminal Deca-His tag added to the chromosomal copy of OafA (cWT OafA-His), the same
strain with unmodified OafA (cWT OafA), and the LT2 basal O-antigen strain with an empty pBADcLIC
plasmid (empty vector). O:5 antibody binding (blue) shows abequose acetylation, and Salmonella LPS
core antibody binding (green) acts as a loading control. (B) Corresponding anti-His Western blot of
insoluble protein fraction for detection of His-tagged OafA. The arrow indicates the full-length OafA
protein.
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pressed in trans in a strain that lacks all O-antigen modification genes, including oafA
(strain 293) (see Materials and Methods; Table S2). Levels of abequose acetylation in
these strains were determined with LPS immunoblotting from the signal obtained with
serotype antibody, and protein expression was also confirmed (Fig. 3, Fig. S2). We
validated this approach by comparing abequose acetylation to both chromosomal
His-tagged OafA and wild-type OafA using the in trans system. This showed that
TABLE 1 Summary of site-directed mutagenesis analysis of the transmembrane domain of OafAa
Mutant
O:5 signal intensity compared
to WT (%  SEM) Position Reason for mutation
R14A 0.07  0.04 TMH1 Specifically conserved in AT3-SGNH proteins
H25A 0.33  0.18 TMH1 Conserved in TMH1 across all aligned proteins
S32A 105.25  30.89 Periplasmic loop and TMH2 XGG-F/Y-XGV-D/P/V-X motif found to be conserved in
AT3-SGNH fused acyltransferases. In the first
periplasmic loop between TMH1-2
G33A 119.17  18.72 Periplasmic loop and TMH2
G34A 1.36  0.88b Periplasmic loop and TMH2
F35A 19.24  2.70 Periplasmic loop and TMH2
I36A 101.47  22.72 Periplasmic loop and TMH2
G37A 118.13  22.11 Periplasmic loop and TMH2
V38A 86.38  12.73 Periplasmic loop and TMH2
D39A 0.31  0.07 Periplasmic loop and TMH2
V40A 121.28  23.82 Periplasmic loop and TMH2
S45A 98.18  24.30 TMH2 Conserved in SG in TMH2
G46A 99.59  22.01 TMH2
R69A 0.10  0.04 TMH3 RXXR motif previously identified as critical for function
R72A 0.07  0.02 TMH3
S112A 0.24  0.09 TMH3-4 Periplasmic loop Conserved in periplasmic loop between TMH3-4 in
AT3-SGNH fused proteinsN113A 93.79  14.92 TMH3-4 Periplasmic loop
Y122A 85.76  7.58 TMH3-4 Periplasmic loop
G202A 74.14  10.70 TMH6 Conserved transmembrane glycine
E325A (linker) 4.84  1.13 TMH10-11 cytoplasmic loop Conserved after TMH10 in all AT3-SGNH fused proteins
aDark gray shading, point mutants with 1% O:5 signal intensity; Light gray shading, point mutants with 50% O:5 signal intensity.
bNo OafA protein expression detected. Values represent the average of 2 biological repeats with 3 technical replicates.
FIG 4 Summary of mutagenesis analysis of S. Typhimurium OafA. A diamond shape indicates residues that were mutated, cysteine residues were mutated to
serine, and all other residues were mutated to alanine. Results relate to the percentage O-antigen acetylation compared to the wild type; mutants that caused
loss of protein expression are diamond shaped but not colored (G34A).
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despite a higher level of protein in the in trans system (Fig. 3B), a comparable level of
abequose acetylation was obtained in all strains (Fig. 3A, Fig. S2).
Twenty positions in the membrane-bound domain of OafA were individually engi-
neered to replace the wild-type amino acid with alanine. The level of O-antigen
acetylation in situ as a result of mutant protein expression is summarized in Table 1 and
Fig. 4, and the data are shown in Fig. S2. Point mutants that gave 1% O-antigen
acetylation signal in relation to the wild type were considered to be inactive, and those
with 50% O-antigen acetylation signal were considered to have significantly reduced
activity. For all mutant proteins except G34A, there was detectable full-length protein
on the Western blot, sometimes in addition to degradation products (Fig. S2). Assay
validation experiments indicate that the levels of full-length mutant protein are in
excess of wild-type levels and thus should be sufficient to confer detectable abequose
O-acetylation.
The arginine and histidine residues in the R/K-X10-H motif (OafAR14 and OafAH25) are
essential for function. These residues are predicted to be on the same surface of the
alpha helix with spacing similar to the predicted distance between the 3= phosphate
and the thioester bond of one coenzyme A molecule (19 Å). Thus, we hypothesize
that these residues provide a potential acetyl-CoA interaction site within the AT3
domain. The 100% conserved glycines (OafAG46 and OafAG202) could be replaced with
alanine with no detriment. As expected, both arginines in the TMH3 RXXR motif
(OafAR69,R72) (9, 57) were essential for OafA function (Table 1, Fig. 4).
We next examined the unique aspects of the AT3 domains among the AT3-SGNH
fused proteins. Of the conserved GG-F/Y-XGV-D/P/V motif and flanking residues, mu-
tation of OafAF35 and OafAD39 caused significant reduction and complete loss of OafA
activity, respectively. OafAS112A mutation also caused complete loss of OafA activity
(Table 1, Fig. 4). AT3-only acetyltransferases do not contain an 11th TMH, but a
glutamate residue after the C-terminal end of TMH10 (OafAE325) is invariant across
AT3-SGNH protein sequences; mutation of this residue (OafAE325A) resulted in signifi-
cant reduction in OafA activity (Table 1, Fig. 4). Thus, AT3-SGNH-specific conserved
residues in the AT3 domain are inherently involved in the mechanism of action of OafA.
OafB-SPAlong has an extended SGNH-like fold. To gain an understanding of the
mechanism of OafA and OafB, both domains must be analyzed; thus, in vitro analysis of
the SGNH domain was conducted. Structural analysis of the SGNH domains and
periplasmic linking regions of OafA and OafB were used to gain insight into the
functional adaptations of an SGNH domain fused directly to an AT3 domain. We
expressed and purified residues 366 to 609 from OafA (OafA-STMC-long) and residues
377 to 640 from S. Paratyphi OafB (OafB-SPAC-long), which have 31% sequence identity
(Fig. 1A). Although OafB-SPA has not been experimentally characterized in the litera-
ture, S. Paratyphi O-antigen rhamnose can be acetylated (58), and OafB-SPA has 78%
sequence identity to the experimentally characterized OafB-STM rhamnose acetyltrans-
ferase (9).
No diffracting crystals of OafA-STMC-long were obtained; however, crystals diffracting
to a 1.1-Å resolution were obtained for OafB-SPAC-long, with a single molecule in the
asymmetric unit. The structure could not be solved by molecular replacement using a
number of known SGNH structures but was solved using Fragon (59) with a 14-residue
ideal polyalanine -helix as the search model and refined to an Rwork/Rfree of 13.6/14.9%
(Table S3).
The core structure of OafB-SPAC-long resembles an SGNH domain with an //
hydrolase fold consisting of five central -strands surrounded by six -helices (Fig. 5A).
Two disulfide bonds are seen in the structure (Fig. 5A) and were verified using mass
spectrometry. The closest structural homologues to OafB-SPAC-long, as identified by the
DALI server, are carbohydrate esterases from Talaromyces cellulolyticus (Protein Data
Bank [PDB] 5B5S) and Clostridium thermocellum (PDB 2VPT); each has a root mean
square deviation (RMSD) of 2.5 Å over 207 and 201 backbone residues, respectively.
Two-Domain Surface Carbohydrate O-Acetyltransferases ®












































The first clear difference between OafB-SPAC-long compared to its closest structural
homologues and the only other SGNH domain from a fused acyltransferase with a
solved crystal structure, OatA-SGNH (PDB 5UFY) (60), is that the structure is significantly
larger, at 36,000 Å3, than OatA-SGNH at 23,000 Å3, which is more similar to the size
of the two most closely related structures of the carbohydrate esterases (PDB 2VPT is
26,000 Å3 and PDB 5B5S is 27,000 Å3). This additional volume in the fold is
contributed by two separate noncontiguous parts of the structure, the first being helix
8, which comprises 10% of the SGNH domain volume (Fig. 5). A structure-based
alignment of related SGNH domains indicated that the sequence forming this addi-
tional helix is only present in AT3-SGNH domains involved in acetylation of LPS
O-antigens (Fig. 6A, Fig. S3) and so is missing on OatA. Second, and most significantly,
the region that connects the end of TM11 and the start of the sequence of other known
SGNH domains (residues 377 to 421) is clearly structured and forms a long extension of
the SGNH domain that we now term the SGNH extension (SGNHext). The SGNHext
interacts extensively with the SGNH domain covering 1,500 Å2 of the SGNH domain,
including interactions with helix 8; 38 amino acids of the SGNH domain interact with
32 (of 48) residues in the extension. Removal of the most N-terminal half of the SGNHext
(OafA-STMC-short and OafB-SPAC-short [Fig. 1A]), results in a decrease in melting temper-
ature of 5.7°C in OafA and 8.9°C in OafB, suggesting that the SGNHext has a stabilizing
effect on the SGNH domain (Fig. S4). These observations show that OafB-SPAC-long
forms an extended SGNH-like fold with an additional helix, and the periplasmic portion
of the linking region is structured and interacts with the SGNH domain.
FIG 5 Analysis of the crystal structure of OafB-SPAC-long. (A) Cartoon representation of OafB-SPAC-long
with helices and sheets numbered, with the additional helix (8) colored teal and SGNH-extension
colored orange. Catalytic residues and disulfide bonds are shown as sticks and are labeled. (B) Surface
representation of OafB-SPAC-long with coloring as above and the catalytic triad colored red. (C) Surface
representation of OafB-SPAlong, PDB 5UFY, PDB 5B5S, and PDB 2VPT.
Pearson et al. ®












































FIG 6 Analysis of additional helix and catalytic triad residues (A and B) Structure-based sequence
alignments of additional helix (A), indicated by a line above the sequence, and blocks I to V (B) with
residues conserved in 50% of sequences highlighted blue; catalytic and oxyanion hole residues are
indicated by an arrow. Abbreviations and details of sequences used are in Materials and Methods. (C)
Catalytic triad and potential oxyanion hole residues are shown as sticks; hydrogen bonds to cocrystallized
sulfate ion are shown as dotted black lines.
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Catalytic residues of OafB-SPAlong resemble a typical SGNH domain with an
atypical oxyanion hole. SGNH domains are usually characterized by the presence of
four blocks of sequence containing conserved residues, block I (GDS), block II (G), block
III (GxND), and block V (DxxH) (where x is any nonproline residue) (22). The structure-
based sequence alignment was used to identify conserved residues in the SGNH
domain of fused acyltransferases (Fig. 6B, Fig. S3). The typical SGNH catalytic triad,
consisting of serine (block I), aspartic acid, and histidine (block V), is conserved in the
sequence of both OafA and OafB. In situ functional analysis of catalytic triad mutants
OafAS412A and OafAH590A showed almost complete loss of function, whereas OafAD587A
showed reduced activity (Table 2, Fig. S2). This is consistent with analyses of typical
catalytic triad activity in other SGNH proteins (61, 62).
While the catalytic triad is conserved in both proteins, the oxyanion hole residues,
glycine (block II) and asparagine (block III), are not (Fig. 6B). Analysis of the structure-
based alignment of the block II region (Fig. 6B, Fig. S3) reveals that the conserved
glycine is replaced by an asparagine in OafB (OafBN459). The structure of OafB-SPAC-long
shows OafBN459 to be within hydrogen-bonding distance of a cocrystallized sulfate ion
(Fig. 6C), suggesting that OafBN459 could interact with bound substrate and participate
in oxyanion hole formation. Homology modeling of OafA-STMC-long based on the
structure of OafB-SPAC-long (Fig. S5) suggests that the OafAS437 side chain or OafAL438
is most likely to replace the block II glycine in the oxyanion hole. This was supported
by the in situ abequose acetylation assay, which shows that OafAS437A has significantly
reduced activity in comparison to wild-type OafA (Table 2, Fig. S2), consistent with the
decrease in activity seen on mutation of the oxyanion hole residues in other SGNH
domains (60, 61, 63).
The GxND motif (block III), where Asn is typically involved in oxyanion hole forma-
tion (20), is not evident in OafA or OafB in the structure-based alignment (Fig. 6B).
OafB-SPAC-long contains a GTNG motif (OafBG502-G505) close to sequence block III
(Fig. 6B), but the side chains of these residues are oriented away from the catalytic triad
(Fig. 6C). These observations suggest that, although OafA and OafB display the typical
catalytic triad of an SGNH domain, their oxyanion hole arrangement is atypical.
The SGNHext confers acceptor specificity. The structured region that extends the
OafB SGNH domain (SGNHext) appears to occlude the active site and results in signif-
icantly lower solvent-accessible surface area (SASA) of the catalytic triad residues (40 Å)
than in OatA, 2VPT, and 5B5S (132 Å, 110 Å, and 126 Å, respectively) (Fig. 5C). Removing
the 22 most N-terminal residues from the structure of OafB-SPAC-long (OafB-SPAC-short;
Fig. 1A) increases the SASA of the catalytic triad residues of OafB to 107.9 Å.
To assess the potential consequences of an occluded active site for substrate
specificity, assays were carried out for OafA and OafB containing the full SGNHext
(OafA-STMC-long and OafB-SPAC-long) and those with half the SGNHext (OafA-STMC-short
and OafB-SPAC-short) (Fig. 1A). In vitro catalytic activity was first confirmed for all
constructs via their ability to hydrolyze the ester substrate p-nitrophenyl acetate





WT (%  SEM) Reason for mutation
C383,397S (linker) 107.40  26.80 Conserved disulfide bonding pairs
C439,453S 185.06  54.63 Conserved disulfide bonding pairs
C567,572S 49.98  4.33 Conserved disulfide bonding pairs
S437A 45.59  3.42 Potential oxyanion hole residue
E569A 99.87  7.01 Conserved between most C-term Cys pair
S412A 0.36  0.26 SGNH domain catalytic triad residues
D587A 10.13  1.70 SGNH domain catalytic triad residues
H590A 0.87  0.62 SGNH domain catalytic triad residues
aDark gray, point mutants with 1% O:5 signal intensity; light gray, point mutants with 50% O:5 signal
intensity. Values represent the average of 2 biological repeats with 3 technical replicates.
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(pNP-Ac) (Fig. S6), an assay commonly used to test SGNH domain function (64, 65). This
activity suggests that all four proteins are correctly folded and catalytically active
regardless of the presence or absence of the SGNHext residues covering the active site
(Fig. S6).
To assess whether SGNHext affects the in vitro acceptor substrate specificity of
OafA-STMC-term and OafB-SPAC-term proteins, purified proteins were incubated with
pNP-Ac (acetyl group donor) and unmodified S. Typhimurium LPS (Path993; Table S2)
as the acceptor substrate, and O:5 antibodies were used to probe for O-antigen
abequose acetylation. Abequose is the native acceptor sugar for OafA, whereas OafB
acetylates rhamnose in situ. A positive signal for O:5 antibody binding is gained after
incubation with OafA-STMC-long and OafA-STMC-short (Fig. 7). Thus, OafA-STMC-long and
OafA-STMC-short are able to acetylate their native substrate in solution. In contrast,
acetylation of the nonnative acceptor substrate by OafB occurs only in the absence of
the OafB SGNHext (OafB-SPAC-short) (Fig. 7). First, these results support our working
model that the SGNH domain performs the last step in the transferase reaction, the
transfer of the acetyl moiety to the acceptor carbohydrate. Furthermore, these results
strongly indicate that the acceptor substrate specificity of this SGNH domain is con-
strained by the cognate, structured SGNHext.
Evolutionary support for an interaction between the AT3 domain and the
SGNH domain. The discovery that the “linker” region that is present between the more
clearly defined AT3 and SGNH domains is, in fact, a long structured component of the
SGNH domain means that the SGNH is much more constrained and proximal to the
membrane than initially proposed if this region was a long flexible linker. The discovery
that there are residues in the AT3 loop between TMH3 and -4 that are only conserved
in the AT3-SGNH fused proteins suggests potential protein-protein contacts between
the two domains during catalysis. To test this hypothesis, we used a coevolution
analysis of the OafA-B type acetyltransferases to assess whether there was any evidence
for correlated changes in the two domains consistent with a physiological interaction
(Fig. S7a). While there are many correlated changes within the two separate domains,
a significant correlated change was observed between residues 95 and 97, located in
the periplasmic loop between TMH3 and -4 of the AT3 domain (Fig. 8) and residues 542
and 545 to 546, which form a surface-accessible patch (Fig. S7b) on the additional helix
FIG 7 Effect of SGNHext length on substrate specificity of C-terminal OafA and OafB. Dot blot for
acetylated abequose (O:5, blue) on basal Salmonella enterica serovar Typhimurium LPS after incubation
with purified C-terminal OafA and OafB and pNPA as an acetyl group donor; 10 M OafA and 20 M OafB
were used in these reactions. Core antibody (green) was used as a loading control. WT acetylated LPS
was used as a positive control. , Active protein; –, heat-treated protein. Representative of n  3 repeats.
“C-long” constructs comprise the SGNH domain with full SGNHext, “C-short” constructs comprise the
SGNH domain with fewer SGNHext residues to expose the SGNH domain active site. See Fig. 1 for details
of the C-terminal OafA and OafB constructs.
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(8) of the SGNH domain (Fig. 8). This predicted interaction further informs our refined
topological model of these AT3-SGNH acetyltransferases (Fig. 8).
DISCUSSION
AT3 domain-containing proteins (PF01757) are a ubiquitous family of proteins
involved in diverse carbohydrate modifications across the domains of life. Prokary-
otic members of this family play roles in modification of antibiotics and antitumor
drugs, as well as initiation of microbial symbioses with plants (15, 66, 67) (Table S1).
In bacterial pathogens, such as Salmonella enterica, Listeria monocytogenes, Hae-
mophilus influenzae, and Streptococcus pneumoniae, these proteins are implicated in
acetylation of extracytoplasmic polysaccharides, which can have significance for
interactions with phage and hosts and can affect virulence and antibiotic resistance
(24, 32, 36, 38). The current experimentally characterized AT3 domain-containing
carbohydrate O-acetyltransferases display SGNH-fused or AT3-only domain architec-
ture. Although both AT3 and SGNH domains display broad substrate ranges in diverse
biological systems, the mechanism of action of both SGNH-fused and AT3-only acetyl-
transferases is largely unknown.
Previous understanding of AT3-SGNH fused acetyltransferases was obtained by in
situ functional assays and structure-function assessment of the SGNH domain (9, 17, 60).
Here, expanded bioinformatic analysis with a set of 30 experimentally characterized
bacterial AT3 acetyltransferases, including AT3-only and AT3-SGNH fused protein se-
quences, which perform a range of biological functions (Table S1), revealed common-
alities and key differences. For example, an R/K-X10-H motif in TMH1 is shared across all
the bacterial AT3 acetyltransferases studied (Fig. 2) and is also highly conserved across
all AT3 domain proteins in the Pfam database (29), strongly suggesting that these are
critical catalytic residues relevant to the whole protein family.
OafAR14 and OafAH25 within this motif were essential for activity (Table 1, Fig. 4) and
are predicted to be at opposite ends, but on the same surface, of the TMH1 helix
(arginine toward the cytoplasmic side), providing a potential interaction site for the
proposed acetyl group donor acetyl-CoA. Although cytoplasmic acetyl-CoA has not
been confirmed as the donor for O-antigen acetylation, it occupies a central role in
bacterial metabolism and is a prominent source of acetate in bacterial cells (68, 69).
Arginine residues were implicated in binding of the 3= phosphate of acetyl-CoA in other
FIG 8 Refined model of AT3-SGNH fused O-antigen acetyltransferases. Periplasmic SGNHext (orange) is
structured, therefore positioning the SGNH domain (gray) close to the AT3 domain (purple); this orients
the additional helix (teal) in close proximity to the AT3 domain with interactions between the two
domains as proposed by the coevolution analysis. These observations result in the current hypothesis: (1)
Cytoplasmic acetyl group donor interacts with conserved Arg in TMH1, the acetyl group is processed and
transferred to the periplasmic side of the inner membrane, and this process involves catalytic His residue
of TMH1. (2) Conserved Asp and Ser mediate transfer of acetate to the SGNH domain. (3) SGNH domain
catalyzes addition of the acetate to specific O-antigen monosaccharide. The active site of the SGNH
domain is highlighted by an asterisk, and interaction site is highlighted by a plus sign ().
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acetyltransferase proteins (70), and conserved histidine residues in the soluble mito-
chondrial carnitine O-acyltransferase coordinate the thioester bond of acyl-CoA with
the carnitine acceptor to catalyze the acyl-transfer reaction (71). Significantly, the
equivalent residue was discovered as a natural histidine to tyrosine point mutation that
decreased function of the Streptococcus pneumoniae capsule acetylation protein WcjE
in clinical isolates (72).
A similar role for a conserved intermembrane histidine residue has also been
suggested for membrane-bound O-acyltransferases containing an MBOAT (InterPro
IPR004299) rather than AT3 domain (73). These observations support a role of the
R/K-X10H motif in coordinating a cytoplasm-derived acetyl-CoA molecule within the
membrane-bound AT3 domain for transfer of the acetyl group to the SGNH domain,
consistent with our model (Fig. 1). AT3 domain-containing proteins are implicated in
transferring a wide range of acyl groups such as succinate, isovalerate, and propionate
(67, 74, 75); these can all be carried by coenzyme-A. The proposed mechanism of acetyl
donor interaction would provide a potential conserved mechanism for transfer of any
of these acyl substituents, supporting the idea that the TMH1 arginine and histidine are
fundamentally important for the mechanism of all AT3 domain-containing acyltrans-
ferases.
Residues specifically conserved in the AT3 domains of AT3-SGNH fused proteins
(OafAF35 and OafAD39 in TMH2 and OafAS112 between TMH3 and -4) are located toward
the periplasmic side of the AT3 domain (Fig. 2); we suggest these are likely to be
important for interaction with the O-antigen substrate or SGNH domain for acetyl
group transfer. In contrast to the essential nature of OafAS112 in the periplasmic loop
between TMH3 and -4, no functional residues have been identified in the equivalent
region of S. flexneri Oac (an AT3-only O-antigen acetyltransferase) (57). Conversely, the
invariant glycine residue OafAG46, which was critical in S. flexneri Oac (OacG53) (Fig. S1)
(31, 57), could be replaced by alanine without affecting the function of OafA. These
observations suggest a divergence between AT3-only and AT3-SGNH fused proteins.
The location of critical residues specific to the AT3-SGNH fused proteins further suggest
that this divergence occurs at the point of acetyl group transfer to the acceptor
substrate.
This study demonstrates that the SGNH domain of OafA is able to acetylate the
abequose of the O-antigen of Salmonella in vitro without the presence of its cognate
fused AT3 domain. This supports the predicted role for SGNH in the final step of acetyl
group transfer to the acceptor substrate in fused acetyltransferases (Fig. 1B). In agree-
ment with this, in the two-component PatA/PatB peptidoglycan acetyltransferase
system, PatB, a soluble SGNH protein, is responsible for transfer of the acetyl group
onto the peptidoglycan substrate (62). Moynihan and Clarke hypothesized that PatA (an
MBOAT protein, not an AT3) is responsible for transporting the acetyl group across the
membrane, where it is transferred to the acceptor by the soluble PatB protein (62). The
membrane-bound PatA MBOAT protein in this system is interchangeable with WecH, an
AT3-only acetyltransferase protein (52, 76), giving an example of direct transfer of
acetate between a membrane-bound AT3 domain and soluble SGNH domain protein.
This supports the mechanistic model of the AT3 domain delivering the acetyl group to
the SGNH domain for transfer onto the acceptor substrate in AT3-SGNH fused proteins
(Fig. 1B).
Our data demonstrated, for the first time in a fused system, the necessity for the
fused SGNH domain in glycan carbohydrate acetylation. However, this poses the
conundrum that other closely related systems, such as OacA from Shigella, which
O-acetylates rhamnose in the O-antigen (57), lack either a fused or genetically linked
partner SGNH domain. Consequently, either the AT3 domain functions differently or
there is a currently undiscovered partner protein.
This study elucidates the structure of the SGNHext in OafB-SPAC-long and shows that
removal of this region results in promiscuity of carbohydrate modification in in vitro
acetyltransferase reactions (Fig. 7). These findings suggest that the SGNHext plays a role
in determining the specificity of the O-antigen residue to be acetylated. Closer exam-
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ination of the structure reveals that two tyrosines, Tyr289 and Tyr394, in the SGNHext sit
close to the active site and could potentially be involved in a mechanism to limit
off-target acetylation. Inadvertent acetylation of complex carbohydrates could poten-
tially have diverse and undesired biological effects due to the variation of cellular
processes that can be affected by acetylation (9, 33, 39, 77–79). Whether this also
suggests that AT3 proteins all need a partner domain or protein for substrate-specific
transferase activity remains to be determined.
Coevolution analysis predicts interaction between periplasmic loops of the AT3
domain and the SGNH domain of OafB. This is similar to the arrangement of domains
seen in PglB, an oligosaccharide transferase from Campylobacter lari (80), with 13 TMH
and a periplasmic domain. In PglB the periplasmic domain interacts via periplasmic
loops in the transmembrane domain, and both domains are hypothesized to interact
with the peptide substrate (80). In our model, the coevolution analysis positions the
periplasmic loops of the AT3 domain close to the 8 helix in the SGNH domain,
allowing for an interaction with each other and with the acceptor substrate (Fig. 8).
AT3 domain-containing proteins are involved in the modification of a wide range of
polysaccharides and influence many host-pathogen interactions. These structural and
functional insights can be applied to the well-studied and biotechnologically relevant
AT3 proteins, including Nod factor modifications important for plant microbe symbio-
sis, and antitumor and antibiotic modifying proteins. Furthermore, this work can inform
future studies of eukaryotic systems where AT3 domain-containing proteins are in-
volved in regulation of the life span of Caenorhabditis elegans (81) and in Drosophila
development (82).
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. Escherichia coli and S. Typhimurium strains and
plasmids are listed in Table S2. Strains were cultured in Lennox broth (LB; Fisher Scientific) at 37°C with
appropriate antibiotic selection unless otherwise stated.
In silico analysis of bacterial AT3 domains to identify conserved residues. A survey of the
literature identified 30 experimentally characterized bacterial carbohydrate acetyltransferases; these
sequences were aligned with OafB from S. Paratyphi A, using T-coffee (83). Protein accession numbers are
in Fig. S1. T-coffee was also used to align the OafA-STM, OafB-STM, and OafB-SPA protein sequences for
direct comparison.
Structure-based sequence alignments using PROMALS3D with default settings were carried out with
the two closest structural homologues identified using the DALI server and a selection of typical SGNH
domains for which structural information is available, OafB-SPA, 1IVN, 4K40, 1DEX, 5UFY, 5B5S, and 2VPT.
Five additional representative sequences of OafA, OafB, and OatA were included (A0A0H2WM30,
STMMW_03911, Q8ZNJ3, NTHI0512, and Q2FV54).
Coevolution analysis. A multiple sequence alignment of AT3 SGNH domain fused proteins was
constructed using the MUSCLE alignment tool based on 1,188 full-length sequences from the UniProt
reference proteomes. This alignment was used to construct a profile hidden Markov model (HMM) to
detect further homologues in the UniProt reference proteome set as well as within the MGnify protein
sequence set. We required that all matches to this profile-HMM had a sequence and domain threshold
of 27 bits. We also required that the sequence matched 90% of the HMM match states to ensure that
homologues with only one of the two domains were not included in the alignment.
A total of 2,713 homologues were identified from the UniProt reference proteome set, and 9,757
homologues were identified from the MGnify metagenomics sequences. A large sequence alignment was
constructed using OafB as the master with no indels with all the sequence matches aligned to it using
the hmmalign package and a custom Perl script to format the alignment for contact prediction. The
alignment was submitted to the RaptorX contact prediction server (84).
Molecular biology. Primers (Sigma-Aldrich) are listed in Table S2. Mutations were introduced into
the OafA sequence (pMV433 as the template), which had been cloned into pBADcLIC using blunt-end
ligation, placing the gene under the control of an arabinose-inducible promoter. Mutants were con-
firmed by sequencing. Plasmids were electroporated into S. Typhimurium strain 293 (Table S2) for
analysis of activity.
All oafA-STM and oafB-SPA sequences for protein expression were cloned into pETFPP_2 (Technology
Facility, University of York) using in-fusion cloning (Clontech) to add a 3C-protease cleavable N-terminal
His-MBP tag. Plasmid pMV433 (Table S2) was used as the template for creation of expression plasmids
encoding the protein sequence for OafA-STMC-long (residues 366 to 609) and OafA-STMC-short (residues
379 to 609). oafB-SPA (UniProt A0A0H2WM30), amino acid residues 377 to 640 for OafB-SPAC-long, was
codon-optimized for E. coli and synthesized by Genewiz in a pUC57-Kan vector. This vector was then used
as a template for the sequence encoding OafB-SPAC-short (residues 399 to 640); see Table S2 for the
primers used.
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In situ functional analysis of OafA variants. All in situ functional analyses of OafA variants cloned
into pBADcLIC were carried out in strain Path293 (23) (Table S2). Strains for the in situ functional analysis
were cultured at pH 7.0 in 100 mM sodium phosphate-buffered LB at 37°C in a baffled conical flask with
shaking at 200 rpm. Overnight cultures were diluted 100-fold and grown for 16 h. Samples were
normalized to an optical density at 600 nm (OD600) of 3.0 per ml for LPS and protein extraction.
Crude LPS sample preparation. The method was adapted from Davies et al. (23). First, 1 ml of
OD-normalized (OD600, 3.0) overnight culture was pelleted for 5 min at 16,000  g. Cell pellets were
resuspended in 100 l LPS sample buffer (60 mM Tris-HCl, 1 mM EDTA, pH 6.8) containing 2% (wt/vol)
SDS and then boiled at 100°C for 5 min. Then, 400 l of LPS buffer was used to dilute the solution before
RNase (Roche) and DNase (Sigma) treatment at 37°C for 16 h. Samples were then treated with 100 g
proteinase K for 16 h at 50°C, and 7.5 l of crude LPS extracts were run on 1.0 mm Tricine SDS poly
acrylamide gel electrophoresis (TSDS-PAGE gel) for analysis by immunoblotting.
Detection of OafA protein expression for in situ assays. First, 1 ml of OD-normalized culture was
pelleted for 5 min at 16,000  g. Soluble and insoluble fractions were isolated from cell pellets using
BugBuster solution (Novagen) following the manufacturer’s instructions for soluble protein extraction.
The insoluble pellet was resuspended in 75 l of sample buffer (10% [vol/vol] glycerol, 1% [wt/vol] SDS,
10 mM Tris-HCl [pH 7.2], 0.06% [wt/vol] bromophenol blue, 3% [vol/vol] -mercaptoethanol), heated to
60°C for 10 min, and centrifuged for 10 min at 16,000  g. Then, 10 l of insoluble fraction samples was
loaded onto a 12% acrylamide 1.0-mm SDS-PAGE gel for analysis.
Immunoblotting. First, 7.5 l of crude LPS extracts was run on 1.0 mm Tricine SDS polyacrylamide
gel electrophoresis (TSDS-PAGE) gel for analysis by immunoblotting. The TSDS-PAGE-separated LPS
samples and SDS-PAGE-separated protein samples were transferred onto Immobilon-P polyvinylidene
difluoride (PVDF) membrane (Merck-Millipore). For His-tagged protein detection, the primary antibody
was Tetra·His antibody (1:1,000) (Qiagen; in 3% [wt/vol] bovine serum albumin [BSA] Tris-buffered saline
[TBS]), and the secondary antibody was goat anti-mouse IgG-HRP (1:10,000) (Sigma-Aldrich; in 5%
[wt/vol] milk TBS). The blot was developed using Luminata Classico Western HRP substrate (Merck-
Millipore). For LPS detection, O:5 serotyping antibody (1:10,000) (Statens Serum Institute; 40272) and
Salmonella core antigen (1:200) (Insight Biotechnology; 5D12A) were used as the primary antibodies and
goat anti-rabbit IgG StarBright Blue700 (1:5,000) (Bio-Rad) and goat anti-mouse IgG (HL) DyLight 800
(1:5,000) as the respective secondary antibodies. LPS antibodies were diluted in 5% milk phosphate-
buffered saline with Tween 20 (PBS-T). The ChemiDoc MP imaging system (Bio-Rad) and Image Lab
(Bio-Rad) were used for image capture and analysis. The in situ activity of OafA mutant relative to the
wild-type protein was derived from quantification of the O:5 signal in each lane, standardized to the
intensity of the single O-antigen repeat band for the Salmonella core signal on LPS immunoblots. Assay
validation demonstrated that 1% of the O:5 signal with respect to the wild type was within the
background variation. Variation increased significantly for signal intensities in the higher range; there-
fore, the O:5 signal recorded between 50 and 100% relative to wild type was not interpreted further.
Expression and purification of OafA-STMC-term and OafB-SPAC-term. The pETFPP_2 vectors con-
taining the inserted OafA-STMC-term and OafB-SPAC-term constructs (Fig. 1) were transformed into Origami
(Novagen) E. coli for protein expression. Protein expression was carried out as described by Gruszka et
al. (85) without the addition of protease inhibitor. The proteins were purified using immobilized metal
affinity chromatography with a HisTrap FF column (GE Healthcare) utilizing a His-tag, followed by size
exclusion chromatography after His-tag removal, as described by Wojdyla et al. (86); purified protein was
eluted in 20 mM Tris-HCl (pH 7.5) and 100 mM NaCl.
Melting temperature of OafA and OafB SGNH domains. The melting temperature of SGNH
domains was determined using NanoDSF with a protein concentration of 1 mg/ml in 20 mM TrisHCl (pH
7.5) and 100 mM NaCl. Proteins were heated from 20°C to 95°C with a heating rate of 2°C/min. The
fluorescence at 330 and 350 nm was measured every 0.05°C.
In vitro acetylesterase activity assay. The catalytic activity of OafA and OafB C-terminal constructs
was confirmed by acetyl esterase activity using pNP-Ac as a substrate. One hundred l of enzyme
solution (10 M OafA-STMC-term, 40 M OafB-STMC-term, or 0.04 U/ml acetyl xylan esterase) or appropriate
control buffers were added to relevant wells of a 96-well plate and incubated at 37°C for 10 min prior to
addition of pNP-Ac. Then, 100 l of 1 mM pNPA in the corresponding buffer was then added to matching
sample and control wells and immediately placed into a plate reader incubated at 37°C. Absorbance at
405 nm was measured at T  0, and then at 5 min intervals.
In vitro abequose acetyltransferase activity assay. Crude LPS extracted from OafA-negative S.
Typhimurium strain LT2 (Path993) was heated at 100°C for 20 min to inactivate the proteinase K (see
above). Heat-treated LPS was mixed 1:1 with KPi buffer (200 mM NaCl, 50 mM potassium phosphate
buffer [pH 7.8]). Next, 10 M OafA-STMC-term and 20 M OafB-SPAC-term were incubated at 4°C in the
LPS-KPi mixture with 4 mM pNP-Ac dissolved in ethanol (4% [vol/vol] final concentration in reaction).
Samples of the reaction mix were taken after specified time points and inactivated by boiling for 10 min.
Then, 5 l of LPS reaction samples were loaded onto methanol-activated PVDF membrane using a
Bio-Rad Bio-Dot microfiltration apparatus. The protocol for LPS detection with O:5 serotyping antibodies
and Salmonella core antigen was followed as per immunoblotting, following removal of the membrane
from the apparatus after sample loading.
Protein structure analysis. To crystallize OafB-SPAC-long, a hanging-drop vapor diffusion method was
used with 20 mg/ml OafB-SPAC-long in a drop ratio of 1:1 protein:reservoir solution. After incubation for
24 h at 20°C, crystals grown in 100 mM BisTris (pH 5.5), 0.25 M lithium sulfate, and 25% PEG 3350 were
cryoprotected by addition of glycerol to a final concentration of 20% and vitrified in liquid nitrogen.
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X-ray diffraction data for crystals of OafB-SPAC-long were collected on beamline I04-1 (Diamond Light
Source, UK) at a wavelength of 0.9282 Å using a Pilatus 6M-F detector. Data were integrated with XDS
(87) and scaled and merged with AIMLESS (88) via the Xia2 pipeline (89). Fragon molecular replacement
(59) used Phaser (90) to place an ideal poly alanine helix of 14 amino acids in length followed by density
modification with ACORN (91). ARP-wARP (92) was used for automated chain tracing, and the model was
refined using REFMAC 5 (93–98). Manual manipulation of the model between refinement cycles was
performed using Coot (99, 100). The final model was evaluated using MolProbity (101) and PDB validate;
the secondary structure shown in Fig. 5A was annotated using STRIDE (102).
A homology model of OafA-STMC-long was produced using SwissModel with the structure of OafB-
SPAC-long as a template (103–107).
Data availability. The atomic coordinates and structure factors have been deposited in the Protein
Data Bank (PDB ID code 6SE1).
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